102 completed, 18 terminated, 15 unknown, 5 recruiting. 147 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 147 | Completed 102, Terminated 18, Unknown 15, Recruiting 5, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1 |
Follow Risperidone: new trials by email Literature Review of Risperidone trials Research Report on Risperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risperidone vs Cariprazine in Acute Mania Risperidone, Cariprazine - Bipolar 1 Disorder | Phase 4 | Not yet recruiting | Pakistan Institute of Medical Sciences | 50 | 2027-06-01 | 2026-06-24 |
| Cerebellum-based Imaging Neural Markers for Antipsychotic Response risperidone, aripiprazole - Psychosis; Acute | Phase 4 | Recruiting | Northwell Health | 120 | 2025-11-01 | 2026-05-26 |
| Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder | Phase 4 | Active not recruiting | Dr. Stavroula Rakitzi | 84 | 2025-06-04 | 2026-05-01 |
| Biomarkers to Enhance Early Schizophrenia Treatment aripiprazole, risperidone, clozapine - Schizophenia Disorder | Phase 4 | Recruiting | Northwell Health | 180 | 2024-09-04 | 2026-07-31 |
| Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia Aripiprazole, Risperidone - Schizophrenia | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 60 | 2024-04-05 | 2025-11-25 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia | Phase 4 | Terminated | Ohio State University | 5 | 2023-08-16 | 2026-02-25 |
| Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine Lumateperone, Risperidone - Psychosis | Phase 4 | Withdrawn | University of New Mexico | 2023-05-11 | 2025-03-05 | |
| "Extended" (Alternate Day) Antipsychotic Dosing Risperidone, Olanzapine, paliperidone - Schizophrenia and Related Disorders, Drug Administration Schedule | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 120 | 2022-06-06 | 2026-04-13 |
| CLOZAPINE Response in Biotype-1 clozapine, risperidone - Schizophrenia, Schizoaffective Disorder | Phase 4 | Recruiting | University of Texas Southwestern Medical Center | 524 | 2022-03-01 | 2026-05-11 |
| A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq. - Schizophrenia | Phase 4 | Completed | Janssen-Cilag International NV | 93 | 2021-07-22 | 2025-04-27 |
| Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building Risperidone, Aripiprazole, Ziprasidone - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 350 | 2021-05-01 | 2020-08-26 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone PERSERIS, Risperidone - Schizophrenia | Phase 4 | Completed | Indivior Inc. | 69 | 2019-06-28 | 2021-07-07 |
| A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq. - Schizophrenia | Phase 4 | Completed | Janssen Research & Development, LLC | 34 | 2018-10-18 | 2025-04-27 |
| A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic Digital Medicine System, Aripiprazole, Olanzapine - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 44 | 2018-05-21 | 2020-07-16 |
| Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia Risperidone - Schizophrenia Spectrum and Other Psychotic Disorders | Phase 4 | Completed | Weill Medical College of Cornell University | 26 | 2017-09-15 | 2024-05-06 |
| A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway risperidone, aripiprazole, bupropion - Diagnosis and Treatment of Depression | Phase 4 | Unknown | Peking University | 300 | 2017-06-01 | 2017-05-12 |
| Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia Risperidone, Risperidone and Ramelteon, Haloperidol - Schizophrenia | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | 120 | 2017-05-01 | 2019-05-03 |
| Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders Methylphenidate, Risperidone - Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 4 | Terminated | Sheba Medical Center | 5 | 2017-02-01 | 2020-03-18 |
| Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder Clozapine, Risperidone, Olanzapine - Bipolar Disorder | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 54 | 2015-10-01 | 2018-10-02 |
Showing 20 of 147. Sign in to see all of them.
Schizophrenia (98) · Psychotic Disorders (42) · Bipolar Disorder (13) · Aggression (6) · Dementia (6) · Alzheimer Disease (5) · Psychomotor Agitation (5) · Attention Deficit Disorder with Hyperactivity (4) · Autistic Disorder (3) · Conduct Disorder (3) · Diabetes Mellitus (3) · Mental Disorders (3) · Metabolic Syndrome (3) · Oppositional Defiant Disorder (3) · Recurrence (3)
Northwell Health (8) · University of California, Los Angeles (6) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (5) · Eli Lilly and Company (4) · Janssen Korea, Ltd., Korea (4) · Central South University (3) · Fundación Marques de Valdecilla (3) · Janssen Pharmaceutica N.V., Belgium (3) · Janssen, LP (3) · Massachusetts General Hospital (3) · Otsuka Pharmaceutical Development & Commercialization, Inc. (3) · All India Institute of Medical Sciences, Bhubaneswar (2) · AstraZeneca (2) · Creighton University (2) · Dartmouth-Hitchcock Medical Center (2)
United States (70) · China (12) · Taiwan (8) · Germany (7) · South Korea (7) · Canada (5) · India (5) · Israel (5) · Greece (4) · Norway (4) · Spain (4) · United Kingdom (4) · Brazil (3) · Czechia (3) · Argentina (2)
Benedicto Crespo-Facorro, Professor (3) · Delbert Robinson, MD (2) · Frederick Petty, MD, PhD (2) · Joseph Biederman, MD (2) · Keith H. Nuechterlein, PhD (2) · Knut Engedal, Ph D (2) · Wei Hao, MD., Ph.D. (2)
PMID 26107752, PMID 37811711, PMID 40779812, PMID 11559786, PMID 12509667, PMID 12823080, PMID 14661862, PMID 14735295, PMID 15000267, PMID 15056517, PMID 15289699, PMID 16172203, PMID 16185814, PMID 16452559, PMID 16585434, PMID 16585435, PMID 16801664, PMID 16831113, PMID 17015817, PMID 17054789, PMID 17151158, PMID 17151159, PMID 17287825, PMID 17321111, PMID 17335321, PMID 17502776, PMID 17667476, PMID 17667477, PMID 17898351, PMID 17917554, PMID 18052570, PMID 18590519, PMID 18794207, PMID 1883257, PMID 18840034, PMID 19228178, PMID 1950621, PMID 19640511, PMID 19814947, PMID 19890258, PMID 20216424, PMID 20231321, PMID 20334680, PMID 20441726, PMID 20457512, PMID 20494268, PMID 20664583, PMID 20688481, PMID 20812791, PMID 20816031
P50MH066286 (2), R01MH037705 (2), R01MH060004 (2), K23MH074540 (1), M01RR000069 (1), N01MH090001 (1), N01MH90001 (1), R01AG021488 (1), R01DA032533 (1), R01MH041573 (1), R01MH045074 (1), R01MH057292 (1), R01MH059312 (1), R01MH060845 (1), R01MH071536 (1)